Compare BLNK & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLNK | SRTS |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.9M | 65.5M |
| IPO Year | 2008 | 2016 |
| Metric | BLNK | SRTS |
|---|---|---|
| Price | $0.71 | $3.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $2.33 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 2.0M | 33.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $126,197,000.00 | $27,482,000.00 |
| Revenue This Year | $5.71 | $2.00 |
| Revenue Next Year | $19.65 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $3.03 |
| 52 Week High | $2.65 | $5.92 |
| Indicator | BLNK | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 37.09 |
| Support Level | $0.63 | $3.66 |
| Resistance Level | $0.73 | $3.92 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 49.75 | 3.03 |
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.